0 likes | 11 Views
Global Heart Failure Drugs Market Breakdown by Application (Reduced Ejection Fraction, Preserved Ejection Fraction) by Type (ACE inhibitors, Beta Blockers, Diuretics, Sacubitril Valsartan, Others) by End User (Hospitals, Specialty Centers) and by Geography (North America, South America, Europe, Asia Pacific, MEA)
E N D
The Global Heart Failure Drugs Market was valued at USD 8.1 Billion in 2024 and is expected to reach USD 14.7 Billion by 2030, growing at a CAGR of 7.4 % during 2024-2030.
Heart Failure Drugs Market Definition & Scope The Heart Failure Drugs Market pertains to the pharmaceutical sector focused on the research, development, production, and distribution of medications specifically designed to treat heart failure. Heart failure is a chronic condition where the heart is unable to pump blood effectively, leading to inadequate circulation of oxygen and nutrients to the body's tissues. The drugs in this market aim to manage symptoms, improve the quality of life for patients, and in some cases, slow the progression of heart failure.
Heart Failure Drugs Market Type ACE inhibitors Beta Blockers Market Type Diuretics 5 4.5 Sacubitril Valsartan 4 3.5 Others 3 2.5 2 1.5 1 0.5 0 Type I Type II Type III Series 1 Series 2 Series 3
Heart Failure Drugs Market by Application Market Application • Reduced Ejection Fraction • Preserved Ejection Fraction 5 4.5 4 3.5 3 2.5 2 1.5 1 0.5 0 Application I Application II Application III Series 1 Series 2 Series 3
Heart Failure Drugs market Key Players Some of the key players profiled in the study are – Johnson & Johnson (United States) Pfizer (United States) Johnson & Johnson (United States) Pfizer (United States) Roche (Switzerland) Novartis (Switzerland) AbbVie (United States) Merck (United States) Bristol-Myers Squibb (United States) Sanofi (France) AstraZeneca (United States) GSK (United Kingdom) • • • • • • • • • • GSK (United Kingdom) Roche (Switzerland ) AstraZenec a (United States) Companies Novartis (Switzerland ) Sanofi (France) Bristol-Myers Squibb (United States) AbbVie (United States) Merck (United States)
Regions If opting for the Global version of Heart Failure Drugs Market; then the below country analysis would be included: • • North America (the USA, Canada, and Mexico) Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland, and the Rest of Europe) Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia, and the Rest of APAC) South America (Brazil, Argentina, Chile, Colombia, the Rest of the countries, etc.) The Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA) • • •
Get Detailed Overview of Report Global Heart Failure Drugs Market Growth 2024-2030 is the latest research study released by HTF MI evaluating the market risk side analysis, highlighting opportunities, and leveraging with strategic and tactical decision-making support. Read Detailed Index of full Research Study at @ https://www.htfmarketintelligence.com/report/global-heart-failure-drugs-market
Contact Us Contact Us : Craig Francis (PR & Marketing Manager) HTF Market Intelligence Consulting Private Limited Phone: +1 434 322 0091 sales@htfmarketintelligence.com Connect with us at LinkedIn | Facebook | Twitter